DE3588095D1 - Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren Benutzung - Google Patents
Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren BenutzungInfo
- Publication number
- DE3588095D1 DE3588095D1 DE3588095T DE3588095T DE3588095D1 DE 3588095 D1 DE3588095 D1 DE 3588095D1 DE 3588095 T DE3588095 T DE 3588095T DE 3588095 T DE3588095 T DE 3588095T DE 3588095 D1 DE3588095 D1 DE 3588095D1
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical composition
- composition containing
- polypeptide
- production process
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/675—Beta-endorphins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59236076A JPH0680079B2 (ja) | 1984-11-09 | 1984-11-09 | ポリペプチド |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3588095D1 true DE3588095D1 (de) | 1996-04-25 |
DE3588095T2 DE3588095T2 (de) | 1996-09-19 |
Family
ID=16995360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3588095T Expired - Fee Related DE3588095T2 (de) | 1984-11-09 | 1985-11-08 | Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren Benutzung |
Country Status (21)
Country | Link |
---|---|
US (1) | US4707468A (de) |
EP (2) | EP0181001B1 (de) |
JP (1) | JPH0680079B2 (de) |
KR (1) | KR880000765B1 (de) |
CN (1) | CN1029684C (de) |
AT (1) | ATE135712T1 (de) |
AU (1) | AU588837B2 (de) |
CA (1) | CA1267997A (de) |
DE (1) | DE3588095T2 (de) |
DK (1) | DK171300B1 (de) |
ES (1) | ES8800272A1 (de) |
FI (1) | FI92935C (de) |
GR (1) | GR852689B (de) |
HU (1) | HU203563B (de) |
IL (1) | IL76924A (de) |
NO (1) | NO169347C (de) |
NZ (1) | NZ214122A (de) |
PH (1) | PH23847A (de) |
PT (1) | PT81441B (de) |
SU (1) | SU1433415A3 (de) |
ZA (1) | ZA858456B (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2673376A1 (fr) * | 1991-03-01 | 1992-09-04 | Lefesvre Andre | Composition pharmaceutique pour le traitement des tumeurs de kaposi. |
US5817628A (en) * | 1992-12-02 | 1998-10-06 | The Rockefeller University | Dynorphin a suppression of natural killer cell activity |
SE9401596D0 (sv) * | 1994-05-06 | 1994-05-06 | Astra Ab | New compounds |
JP3385147B2 (ja) * | 1996-01-31 | 2003-03-10 | ユニ・チャーム株式会社 | 男性用尿とり袋 |
AU3499997A (en) * | 1996-06-24 | 1998-01-14 | Rockefeller University, The | Method of using ligands of the kappa opioid receptor |
CA2321026A1 (en) * | 1998-03-09 | 1999-09-16 | Zealand Pharmaceuticals A/S | Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
US6232287B1 (en) * | 1998-03-13 | 2001-05-15 | The Burnham Institute | Molecules that home to various selected organs or tissues |
IL137820A (en) * | 2000-08-10 | 2009-06-15 | S I S Shulov Inst For Science | Pharmaceutical composition for topical administration comprising an analgesic peptide |
ATE476971T1 (de) * | 2000-08-25 | 2010-08-15 | Res Corp Technologies Inc | Aminosäure enthaltende antikonvulsiva zur behandlung von zwangsstörungen |
ES2262567T3 (es) * | 2001-03-20 | 2006-12-01 | Schwarz Pharma Ag | Nuevo uso de una clase peptidica de compuesto para tratamiento del dolor inflamatorio no neuropatico. |
DE60100055T2 (de) * | 2001-03-21 | 2003-07-24 | Sanol Arznei Schwarz Gmbh | Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen |
US7622446B2 (en) * | 2001-04-18 | 2009-11-24 | The Open University | Polypeptides, derivatives and uses thereof |
US7491702B2 (en) * | 2001-04-18 | 2009-02-17 | The Open University | Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same |
EP1734980A1 (de) | 2004-04-16 | 2006-12-27 | Schwarz Pharma Ag | Verwendung peptidähnlicher verbindungen zur vorbeugung und behandlung chronischer kopfschmerzen |
CA2573125A1 (en) * | 2004-08-27 | 2006-03-02 | Schwarz Pharma Ag | Novel use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
EP1754476A1 (de) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamid (SPM 927) zur Behandlung von Myalgien, z.B. Fibromyalgie |
US20070048372A1 (en) * | 2005-08-18 | 2007-03-01 | Srz Properties, Inc. | Method for treating non-inflammatory osteoarthritic pain |
US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
GB2432586B (en) * | 2005-11-25 | 2010-01-13 | Univ Open | Treatment of neurodegenerative disorders |
EA019757B1 (ru) * | 2006-06-15 | 2014-06-30 | ЮСиБи ФАРМА ГМБХ | Фармацевтическая композиция с синергетическим противосудорожным эффектом |
RU2010114058A (ru) * | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | Применение пептида в качестве терапевтического средства |
JP2010539049A (ja) * | 2007-09-11 | 2010-12-16 | モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト | サイモシンβ4の単独、またはセクロピンAとの組合せでの、治療剤としてのペプチドの使用 |
JP6901801B2 (ja) * | 2017-06-14 | 2021-07-14 | バイオソリューション カンパニー・リミテッドBio Solution Co Ltd | 物質pを含むしわの改善または抗炎症化粧料組成物 |
TW201920234A (zh) | 2017-09-11 | 2019-06-01 | 美商領導醫療有限公司 | 類鴉片促效劑肽及其用途 |
CA3188556A1 (en) * | 2020-07-01 | 2022-01-06 | PreveCeutical Medical Inc. | Peptides and uses thereof |
RU2760133C1 (ru) * | 2021-04-22 | 2021-11-22 | Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства". | Амиды гептапептида для лечения HMGB1-зависимых заболеваний |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7700785A (nl) * | 1976-01-26 | 1977-07-28 | Wellcome Found | Biologisch actieve peptiden ter vervanging van morfine. |
US4254106A (en) * | 1976-01-26 | 1981-03-03 | Burroughs Wellcome Co. | Biologically active amides |
US4123523A (en) * | 1976-06-21 | 1978-10-31 | Imperial Chemical Industries Limited | Analgesic and sedative polypeptides |
US4371463A (en) * | 1977-02-17 | 1983-02-01 | The United States Of America As Represented By The Department Of Health And Human Services | Enzyme-resistant opiate pentapeptides |
US4081434A (en) * | 1977-03-11 | 1978-03-28 | Hoffmann-La Roche Inc. | Novel analogs of β-endorphin |
US4139504A (en) * | 1977-06-16 | 1979-02-13 | Coy David Howard | Novel nonapeptides, intermediates therefor, and compositions and methods employing said nonapeptides |
US4127533A (en) * | 1977-06-16 | 1978-11-28 | Coy David Howard | Novel octapeptides, intermediates therefor, and compositions and methods employing said octapeptides |
GB1604850A (en) * | 1977-11-24 | 1981-12-16 | Wellcome Found | Biologically active peptides |
US4148786A (en) * | 1978-06-26 | 1979-04-10 | American Home Products Corporation | Analgesic polypeptide |
US4178284A (en) * | 1978-12-11 | 1979-12-11 | American Home Products Corporation | Octapeptides |
DE2936099A1 (de) * | 1979-09-06 | 1981-04-02 | Victor Dipl.- Chem. 8000 München Brantl | Pharmakologisch aktive peptide |
EP0044451B1 (de) * | 1980-07-17 | 1984-04-18 | Sandoz Ag | Pentapeptide, Verfahren zu deren Herstellung, deren pharmazeutische Zusammensetzungen und deren Anwendung |
JPS57134451A (en) * | 1981-02-13 | 1982-08-19 | Suntory Ltd | Peptide opioide |
EP0076676B1 (de) * | 1981-10-05 | 1986-12-30 | Tni Pharmaceuticals, Inc. | Verfahren zur Verwendung von Endorphinen als Antitumormittel |
US4462941A (en) * | 1982-06-10 | 1984-07-31 | The Regents Of The University Of California | Dynorphin amide analogs |
JPS59141547A (ja) * | 1983-02-01 | 1984-08-14 | Eisai Co Ltd | 鎮痛作用を有する新規ペプタイドおよび製法 |
US4518711A (en) * | 1983-05-16 | 1985-05-21 | Gibson-Stephens Institute | Conformationally constrained cyclic enkephalin analogs with delta receptor specificity |
-
1984
- 1984-11-09 JP JP59236076A patent/JPH0680079B2/ja not_active Expired - Lifetime
-
1985
- 1985-10-28 FI FI854227A patent/FI92935C/fi not_active IP Right Cessation
- 1985-11-02 CN CN85109722A patent/CN1029684C/zh not_active Expired - Lifetime
- 1985-11-04 KR KR8508213A patent/KR880000765B1/ko not_active IP Right Cessation
- 1985-11-04 PH PH33004A patent/PH23847A/en unknown
- 1985-11-04 ZA ZA858456A patent/ZA858456B/xx unknown
- 1985-11-04 IL IL76924A patent/IL76924A/xx not_active IP Right Cessation
- 1985-11-06 AU AU49389/85A patent/AU588837B2/en not_active Ceased
- 1985-11-06 PT PT81441A patent/PT81441B/pt not_active IP Right Cessation
- 1985-11-06 HU HU854270A patent/HU203563B/hu not_active IP Right Cessation
- 1985-11-06 SU SU3974503A patent/SU1433415A3/ru active
- 1985-11-07 DK DK513385A patent/DK171300B1/da not_active IP Right Cessation
- 1985-11-07 ES ES548667A patent/ES8800272A1/es not_active Expired
- 1985-11-07 NO NO854435A patent/NO169347C/no not_active IP Right Cessation
- 1985-11-07 GR GR852689A patent/GR852689B/el unknown
- 1985-11-08 NZ NZ214122A patent/NZ214122A/xx unknown
- 1985-11-08 EP EP85114226A patent/EP0181001B1/de not_active Expired - Lifetime
- 1985-11-08 CA CA000494974A patent/CA1267997A/en not_active Expired - Fee Related
- 1985-11-08 EP EP94107769A patent/EP0614913A3/de not_active Withdrawn
- 1985-11-08 US US06/796,390 patent/US4707468A/en not_active Expired - Lifetime
- 1985-11-08 AT AT85114226T patent/ATE135712T1/de not_active IP Right Cessation
- 1985-11-08 DE DE3588095T patent/DE3588095T2/de not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3588095T2 (de) | Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren Benutzung | |
ATE71375T1 (de) | Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeure ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen. | |
FI906438A0 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi | |
ATE21699T1 (de) | Verfahren zur herstellung von 2-penemverbindungen. | |
ZA904196B (en) | Process for the preparation of a pharmaceutical composition for the treatment of autoimmune diseases | |
ZA806399B (en) | New 2-hydroxyalkyl-3,4,5-trihydroxypiperidine compounds, their production and their medicinal use | |
HU904201D0 (en) | Process for producing peptides with haemoregulating effect and pharmaceutical preparatives containing these compounds | |
GR76886B (de) | ||
EP0241292A3 (de) | Schmerzlindernde, in 4-Stellung substituierte Octahydrochinolizin-Verbindungen und Octahydrochinolizinium Zwischenprodukte | |
AU562271B2 (en) | Pharmaceutical composition of corazepam and diphenhydramine | |
ATE10934T1 (de) | Peptid, verfahren zu dessen herstellung und dessen verwendung. | |
DE3578065D1 (de) | 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate, verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten. | |
DE58909745D1 (de) | Tetrahydro-4-phenylimino-3-thiophenessigsäuren | |
DE58909563D1 (de) | 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |